Singapore markets closed

Recursion Pharmaceuticals, Inc. (RXRX)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
8.28-0.59 (-6.65%)
At close: 04:00PM EDT
8.37 +0.09 (+1.09%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
45,233
43,876
39,681
10,000
3,413
-
Cost of revenue
41,305
42,587
48,275
0
-
-
Gross profit
3,928
1,289
-8,594
10,000
-
-
Operating expenses
Research development
262,109
241,226
155,696
135,271
63,319
-
Selling general and administrative
119,356
110,822
81,599
57,682
25,258
-
Total operating expenses
380,463
351,349
237,133
192,775
88,028
-
Operating income or loss
-376,535
-350,060
-245,727
-182,775
-84,615
-
Interest expense
98
97
55
2,952
1,360
-
Total other income/expenses net
-824
-1,087
52
-825
-1,367
-
Income before tax
-358,953
-332,128
-239,476
-186,479
-87,006
-
Income tax expense
-4,841
-4,062
0
0
-
-
Income from continuing operations
-354,112
-328,066
-239,476
-186,479
-87,006
-
Net income
-354,112
-328,066
-239,476
-186,479
-87,006
-
Net income available to common shareholders
-354,112
-328,066
-239,476
-186,479
-87,006
-
Basic EPS
-1.46
-
-1.36
-1.49
-0.77
-0.55
Diluted EPS
-1.46
-
-1.36
-1.49
-0.77
-0.55
Basic average shares
198,763
-
175,537
125,348
112,466
112,466
Diluted average shares
198,763
-
175,537
125,348
112,466
112,466